Pharmacodynamics, pharmacokinetics, safety, and tolerability of a ready-to-use, room temperature, liquid stable glucagon administered via an autoinjector pen to youth with type 1 diabetes.
Bruce A BuckinghamJennifer L SherrSteven J PrestrelskiValentina ConoscentiPublished in: Pediatric diabetes (2022)
Age-appropriate dosing of this glucagon formulation was effective at 30 min in reversing plasma glucose concentrations from < 80 mg/dL in youth with T1D.